Aaron N. Endsley

1.0k total citations
19 papers, 616 citations indexed

About

Aaron N. Endsley is a scholar working on Immunology, Nephrology and Molecular Biology. According to data from OpenAlex, Aaron N. Endsley has authored 19 papers receiving a total of 616 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Nephrology and 5 papers in Molecular Biology. Recurrent topics in Aaron N. Endsley's work include Renal Diseases and Glomerulopathies (6 papers), HIV Research and Treatment (4 papers) and Platelet Disorders and Treatments (3 papers). Aaron N. Endsley is often cited by papers focused on Renal Diseases and Glomerulopathies (6 papers), HIV Research and Treatment (4 papers) and Platelet Disorders and Treatments (3 papers). Aaron N. Endsley collaborates with scholars based in United States and United Kingdom. Aaron N. Endsley's co-authors include Douglas S. Watson, Leaf Huang, Rodney J. Y. Ho, Carol E. Green, Andrey A. Kolokoltsov, Peter B. Madrid, Ian D. Manger, Robert A. Davey, Amy C. Shurtleff and Travis K. Warren and has published in prestigious journals such as FEBS Letters, Journal of the American Society of Nephrology and Vaccine.

In The Last Decade

Aaron N. Endsley

18 papers receiving 605 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aaron N. Endsley United States 10 252 224 192 76 61 19 616
Clare F. Price United Kingdom 11 223 0.9× 117 0.5× 67 0.3× 157 2.1× 69 1.1× 15 865
Jennifer M. Smith United States 14 111 0.4× 87 0.4× 195 1.0× 93 1.2× 31 0.5× 24 603
Javier García‐Pérez Spain 18 269 1.1× 372 1.7× 283 1.5× 129 1.7× 12 0.2× 42 1.1k
Cuiling Zhang China 10 299 1.2× 171 0.8× 167 0.9× 50 0.7× 16 0.3× 25 741
Qing‐Lei Zeng China 16 170 0.7× 260 1.2× 122 0.6× 241 3.2× 33 0.5× 44 808
Kevin J. Peine United States 16 288 1.1× 88 0.4× 358 1.9× 98 1.3× 101 1.7× 21 737
F. Albano Italy 17 302 1.2× 149 0.7× 77 0.4× 70 0.9× 28 0.5× 44 705
P. White United States 9 214 0.8× 68 0.3× 85 0.4× 236 3.1× 15 0.2× 11 624

Countries citing papers authored by Aaron N. Endsley

Since Specialization
Citations

This map shows the geographic impact of Aaron N. Endsley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron N. Endsley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron N. Endsley more than expected).

Fields of papers citing papers by Aaron N. Endsley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aaron N. Endsley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron N. Endsley. The network helps show where Aaron N. Endsley may publish in the future.

Co-authorship network of co-authors of Aaron N. Endsley

This figure shows the co-authorship network connecting the top 25 collaborators of Aaron N. Endsley. A scholar is included among the top collaborators of Aaron N. Endsley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aaron N. Endsley. Aaron N. Endsley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Bunin, Deborah I., Kyuri Kim, Toufan Parman, et al.. (2024). Evaluation of dimethandrolone undecanoate in non‐human primates as a candidate for long‐acting injectable male contraceptive. Andrology. 13(7). 1919–1934. 3 indexed citations
2.
Barratt, Jonathan, Laura Kooienga, Irfan Agha, et al.. (2022). MO212: Updated Interim Results of A Phase 1/2 Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Activity of BION-1301 in Patients With IGA Nephropathy. Nephrology Dialysis Transplantation. 37(Supplement_3). 5 indexed citations
3.
Barratt, Jonathan, Laura Kooienga, Sujoy B. Roy, et al.. (2022). POS-109 INTERIM RESULTS OF PHASE 1 AND 2 TRIALS TO INVESTIGATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, PHARMACODYNAMICS, AND CLINICAL ACTIVITY OF BION-1301 IN PATIENTS WITH IgA NEPHROPATHY. Kidney International Reports. 7(2). S46–S46. 11 indexed citations
4.
Wall, Jonathan S., Emily B. Martin, Aaron N. Endsley, et al.. (2021). First in Human Evaluation and Dosimetry Calculations for Peptide 124I-p5+14—a Novel Radiotracer for the Detection of Systemic Amyloidosis Using PET/CT Imaging. Molecular Imaging and Biology. 24(3). 479–488. 16 indexed citations
5.
6.
Barratt, Jonathan, Brian S. Schwartz, Bess Sorensen, et al.. (2021). Pharmacodynamic and Clinical Responses to BION-1301 in Patients with IgA Nephropathy: Initial Results of a Ph1/2 Trial. Journal of the American Society of Nephrology. 32(10S). 509–509. 2 indexed citations
7.
Zandvoort, Peter van, Aaron N. Endsley, Thomas Müller, et al.. (2020). P0500RESULTS OF A PHASE 1 TRIAL TO INVESTIGATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF BION-1301 IN HEALTHY VOLUNTEERS. Nephrology Dialysis Transplantation. 35(Supplement_3). 1 indexed citations
8.
Endsley, Aaron N., et al.. (2020). Results of a Phase 1 Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BION-1301 in Healthy Volunteers. Journal of the American Society of Nephrology. 31(10S). 574–574. 1 indexed citations
9.
Kreijtz, Joost H. C. M., Peter van Zandvoort, Aaron N. Endsley, et al.. (2020). P0379BION-1301, A FULLY BLOCKING ANTIBODY TARGETING APRIL FOR THE TREATMENT OF IGA NEPHROPATHY: ASSESSMENT OF SAFETY, PHARMACOKINETICS AND PHARMACODYNAMICS IN LONG-TERM NONCLINICAL STUDIES. Nephrology Dialysis Transplantation. 35(Supplement_3). 1 indexed citations
10.
Wang, Jing‐Hung, Aaron N. Endsley, Carol E. Green, & A. Matin. (2016). Utilizing native fluorescence imaging, modeling and simulation to examine pharmacokinetics and therapeutic regimen of a novel anticancer prodrug. BMC Cancer. 16(1). 524–524. 7 indexed citations
11.
Madrid, Peter B., Rekha G. Panchal, Travis K. Warren, et al.. (2015). Evaluation of Ebola Virus Inhibitors for Drug Repurposing. ACS Infectious Diseases. 1(7). 317–326. 184 indexed citations
12.
Choi, Taylor A., Aaron N. Endsley, Deborah I. Bunin, et al.. (2015). Biodistribution of the Multidentate Hydroxypyridinonate Ligand [14C]‐3,4,3‐LI(1,2‐HOPO), a Potent Actinide Decorporation Agent. Drug Development Research. 76(3). 107–122. 16 indexed citations
13.
Harrison, Mike T., Annalisa D’Andrea, Aaron N. Endsley, et al.. (2013). β-Carotene Biosynthesis in Probiotic Bacteria. Probiotics and Antimicrobial Proteins. 5(2). 69–80. 15 indexed citations
14.
15.
Endsley, Aaron N. & Rodney J. Y. Ho. (2012). Enhanced Anti-HIV Efficacy of Indinavir After Inclusion in CD4-Targeted Lipid Nanoparticles. JAIDS Journal of Acquired Immune Deficiency Syndromes. 61(4). 417–424. 41 indexed citations
16.
Watson, Douglas S., Aaron N. Endsley, & Leaf Huang. (2012). Design considerations for liposomal vaccines: Influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens. Vaccine. 30(13). 2256–2272. 256 indexed citations
17.
Endsley, Aaron N. & Rodney J. Y. Ho. (2012). Design and Characterization of Novel Peptide-Coated Lipid Nanoparticles for Targeting Anti-HIV Drug to CD4 Expressing Cells. The AAPS Journal. 14(2). 225–235. 23 indexed citations
18.
Endsley, Aaron N., Noha N. Salama, & Rodney J. Y. Ho. (2008). Combining Drug and Immune Therapy: A Potential Solution to Drug Resistance and Challenges of HIV Vaccines?. Current HIV Research. 6(5). 401–410. 3 indexed citations
19.
Salama, Noha N., Aaron N. Endsley, & Rodney J. Y. Ho. (2006). Recent Developments in Drug Targets and Delivery of Anti-HIV Drugs. Infectious Disorders - Drug Targets. 6(2). 107–119. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Clare F. Price Breakdown of academic impact, for papers by Jennifer M. Smith Breakdown of academic impact, for papers by Javier García‐Pérez Breakdown of academic impact, for papers by Cuiling Zhang Breakdown of academic impact, for papers by Qing‐Lei Zeng Breakdown of academic impact, for papers by Kevin J. Peine Breakdown of academic impact, for papers by F. Albano Breakdown of academic impact, for papers by P. White
Rankless by CCL
2026